Wegovy Pill vs Injection: What Exists in India, What Doesn't, and Which Oral Semaglutide You Can Actually Get
The Wegovy pill launched in the US in January 2026. In India, the only oral semaglutide on the shelf is still Rybelsus, licensed for diabetes. Here is what each version does, why the pill is not simply the injection without the needle, and what to take if you want to avoid injecting.
ALTRcare Medical Team
Clinical Editorial
"Is there a Wegovy tablet?" is one of the most common questions our doctors get, and the answer needs four sentences, not one. Yes, a Wegovy pill exists. No, it is not sold in India. Yes, there is an oral semaglutide in India, called Rybelsus, and it is licensed for type 2 diabetes at doses too low for serious weight loss. And no, the pill is not the injection with the needle removed: it has rules the injection does not, and it works a little less well.
The four semaglutide products, untangled
| Product | Form and dose | Licensed for | In India? |
|---|---|---|---|
| Wegovy injection | Weekly pen, 0.25 to 2.4 mg | Obesity | Yes, since June 2025; also as Poviztra (Emcure) |
| Ozempic injection | Weekly pen, 0.25 to 1 mg | Type 2 diabetes | Yes; also as Extensior (Abbott) |
| Generic semaglutide pens | Weekly pen or vial, 0.25 to 2.4 mg | Obesity and diabetes, brand-dependent | Yes, 40+ brands since March 2026 |
| Rybelsus tablet | Daily, 3 / 7 / 14 mg, empty stomach | Type 2 diabetes | Yes, since 2022 |
| Wegovy pill | Daily, 1.5 to 25 mg, empty stomach | Obesity | No. US launch January 2026; named-patient import only |
Pill vs injection: results
The Wegovy pill at its full 25 mg dose produced about 14% average weight loss over 64 weeks in the OASIS 4 trial (about 17% among people who stayed on it the whole time). The weekly injection at 2.4 mg produced about 15% over 68 weeks in STEP 1. So the pill is close, not equal. The reason it needs 25 mg to match what 2.4 mg does by injection is that only about 1% of a swallowed peptide gets absorbed, even with the absorption enhancer built into the tablet.
Rybelsus is a different story. Its top dose is 14 mg and its trials were in diabetes, where it produced 3 to 5 kg of weight loss. Some doctors prescribe it off-label for weight, and some patients do lose more, but it is not a weight-loss drug at those doses and it is priced like a branded diabetes drug.
Pill vs injection: the rules
- Empty stomach. Both oral semaglutides must be taken on waking with no more than half a glass of plain water, then nothing to eat, drink or take for 30 minutes. Chai first thing is out. Miss the window and the dose is largely wasted.
- Every day. A weekly injection is one decision a week. A daily tablet is seven, and adherence studies show people forget.
- Same side effects. Nausea, constipation and reflux are similar to the injection at equivalent effect; the daily dosing makes them steadier rather than milder.
- No fridge. The one clear win for the pill. Tablets travel.
What to do if you cannot face injecting
First, know that most people who say this change their mind after one injection. The pen needle is 4 mm and 32 gauge, thinner than a hair, and the sensation is a pinch that lasts a second. Our doctors walk every patient through the first injection on a video call, and the fear is usually gone by week two. Read does semaglutide injection hurt before you rule it out.
If it is a hard no, your options in India today are Rybelsus off-label at 14 mg, with modest results, or waiting for a licensed weight-loss tablet. Orforglipron, Lilly's daily tablet that needs no empty stomach, is the more likely first arrival; we track it in this guide. The Wegovy pill's Indian timeline is unknown, and Novo's Indian focus in 2026 has been on defending the injection against generics.
The honest recommendation
If you can inject, inject. The weekly pen gives you the best results, the most data, the lowest price since the generics, and a doctor can adjust the dose precisely. If you truly cannot, talk to a doctor about Rybelsus now and a licensed tablet later, rather than importing something unlicensed.
Worried about the needle?
Take the free assessment and book a free consultation. Tell the doctor. Your first injection is done together on video, and most people never think about it again.
Key takeaways
- The Wegovy pill (oral semaglutide 25 mg) is sold in the US since January 2026 and not in India.
- Rybelsus is the only oral semaglutide in India, licensed for diabetes at 3 to 14 mg; modest weight loss.
- Pill results are close to the injection (about 14% vs 15%) but it must be taken daily on an empty stomach with a 30-minute wait.
- Needle fear is usually gone after the first supervised injection; the weekly pen remains the best option in India.
Frequently asked questions
Is the Wegovy pill available in India?
No. Oral Wegovy (semaglutide 25 mg tablets) launched in the US in January 2026 but has not been launched in India. Only named-patient imports exist, which are expensive and need DCGI paperwork.
Can I take Rybelsus for weight loss in India?
Rybelsus is licensed for type 2 diabetes at 3, 7 and 14 mg. Some doctors prescribe it off-label for weight; results are modest, typically 3 to 5 kg. It is not equivalent to the Wegovy pill.
Does the Wegovy pill work as well as the injection?
Nearly. About 14% average weight loss at 25 mg over 64 weeks versus about 15% for the 2.4 mg injection over 68 weeks. It must be taken daily on an empty stomach.
Which weight-loss tablet will come to India first?
Most likely orforglipron (Foundayo), Eli Lilly's non-peptide tablet, which Lilly has said it plans to launch in India. No date or price has been announced.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
